Targeting Extracellular DNA to Deliver IGF-1 to the Injured Heart
Citations Over TimeTop 11% of 2014 papers
Abstract
There is a great need for the development of therapeutic strategies that can target biomolecules to damaged myocardium. Necrosis of myocardium during a myocardial infarction (MI) is characterized by extracellular release of DNA, which can serve as a potential target for ischemic tissue. Hoechst, a histological stain that binds to double-stranded DNA can be conjugated to a variety of molecules. Insulin-like growth factor-1 (IGF-1), a small protein/polypeptide with a short circulating-half life is cardioprotective following MI but its clinical use is limited by poor delivery, as intra-myocardial injections have poor retention and chronic systemic presence has adverse side effects. Here, we present a novel delivery vehicle for IGF-1, via its conjugation to Hoechst for targeting infarcted tissue. Using a mouse model of ischemia-reperfusion, we demonstrate that intravenous delivery of Hoechst-IGF-1 results in activation of Akt, a downstream target of IGF-1 and protects from cardiac fibrosis and dysfunction following MI.
Related Papers
- → Application of recombinant TGF-β1 inhibitory peptide to alleviate isoproterenol-induced cardiac fibrosis(2023)13 cited
- → Therapeutic Potential of Polyphenols in Cardiac Fibrosis(2018)48 cited
- → Targeting protein kinase B/Akt signaling with vanadium compounds for cardioprotection(2008)18 cited
- Abstract 19614: IL 10 Inhibits Fibroblast Progenitor Cells Mediated Cardiac Fibrosis in Pressure Overloaded Myocardium(2016)
- → Spatial Mapping of Fibroblast Distribution and Heterogeneity Reveals Striking Sex-Specific Patterns of Hypertension-Induced Cardiac Fibrosis(2023)